Line 1,910: |
Line 1,910: |
| | | | | |
| | | | | |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
| |- | | |- |
| |IgM monoclonal gammopathy of undetermined significance||Disease|| || || || || ||SG|| || | | |IgM monoclonal gammopathy of undetermined significance||Disease|| || || || || ||SG|| || |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
| |- | | |- |
| |Non-IgM monoclonal gammopathy of undetermined significance||Disease|| || || || || ||SG|| || | | |Non-IgM monoclonal gammopathy of undetermined significance||Disease|| || || || || ||SG|| || |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
| |- | | |- |
| |Monoclonal gammopathy of renal significance||Disease|| || || || || ||SG | | |Monoclonal gammopathy of renal significance||Disease|| || || || || ||SG |
| | || | | | || |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
| |- | | |- |
| |Immunoglobulin-related (AL) amyloidosis||Disease|| || || || || ||SG | | |Immunoglobulin-related (AL) amyloidosis||Disease|| || || || || ||SG |
| | || | | | || |
− | | | + | |Primary Amyloidosis |
| |Heather E. Williams, PhD, MS, PgD, ErCLG | | |Heather E. Williams, PhD, MS, PgD, ErCLG |
− | | | + | |?PENDING<br /> |
| | | | | |
| | | | | |
Line 1,948: |
Line 1,948: |
| |Monoclonal immunoglobulin deposition disease||Disease|| || || || || ||SG | | |Monoclonal immunoglobulin deposition disease||Disease|| || || || || ||SG |
| | || | | | || |
− | | | + | |Light Chain and Heavy Chain Deposition Disease |
| |Chen Yang, MD, PhD, University of Michigan | | |Chen Yang, MD, PhD, University of Michigan |
− | | | + | |Complete |
− | | | + | |10/15/2022 |
| | | | | |
| |- | | |- |
| |Mu heavy chain disease||Disease|| || || || || ||SG | | |Mu heavy chain disease||Disease|| || || || || ||SG |
| | || | | | || |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
| |- | | |- |
| |Gamma heavy chain disease||Disease|| || || || || ||SG | | |Gamma heavy chain disease||Disease|| || || || || ||SG |
| | || | | | || |
− | | | + | |Gamma Heavy Chain Disease |
| |Manisha Brahmbhatt-Sutariya Asst. Professor, Dept. of Pathology and Human Anatomy Technical Supervisor, Clinical Genetics Laboratory Loma Linda University, Medical Center, CA | | |Manisha Brahmbhatt-Sutariya Asst. Professor, Dept. of Pathology and Human Anatomy Technical Supervisor, Clinical Genetics Laboratory Loma Linda University, Medical Center, CA |
− | | | + | |Complete |
− | | | + | |5/26/2021 |
| | | | | |
| |- | | |- |
| |Alpha heavy chain disease||Disease|| || || || || ||SG | | |Alpha heavy chain disease||Disease|| || || || || ||SG |
| | || | | | || |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
| |- | | |- |
− | |Plasmacytoma||Disease|| || || || || ||SG | + | |Plasmacytoma||Disease|| || || || ||author needs to include Solitary plasmacytoma of bone, Extraosseous plasmacytoma (extramedullary) (v4 page did not have content on ccga) |
| + | |SG |
| | || | | | || |
− | | | + | |NEW (No Prior) - no content on version 4 page "Plasmacytoma' originally assigned to Zhenya Tang |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
| |- | | |- |
− | |Plasma cell myeloma / multiple myeloma||Disease|| || || || || ||SG | + | |Plasma cell myeloma / multiple myeloma||Disease|| || || || ||Note: author needs to include Plasma_Cell_Myeloma_Variants content in this page||SG |
| | || | | | || |
− | | | + | |(1) Plasma Cell Myeloma + (2) Plasma Cell Myeloma Variants |
− | |*Huan Mo, MD, MS *Zhenya Tang, MD, PhD The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas | + | |(1) Huan Mo, MD, MS and Zhenya Tang, MD, PhD The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas + (2) Fariborz Rashid-Kolvear, PhD, FACMG, FCCMG |
− | | | + | |Pending |
| | | | | |
| | | | | |